Two aquaculture technology companies have lost a three-year legal battle that accused a rival, London-based Neptune Pharma, of exploiting trade secrets related to sea lice treatments
FISH Vet Group (FVG) and Benchmark Animal Health Group (Benchmark) had sued the company in Norway alleging that Neptune directors Victor and Adrian Endacott stole intellectual property relating to FVG’s sea lice control product Salmosan after providing consultancy services to Benchmark CEO Malcolm Pye [...]
Want to keep reading?
Sign up for a trial to have full access to our articles for 7 days!
Have an account? Log in here:
Enter the email address associated with your account. We'll send you instructions to reset your password.
We’ve sent a link to to change your password.
Please check your inbox to reset your password securely and easily.